Dragon Pharma IGF-1 LR3
For athletes, bodybuilders, and fitness enthusiasts seeking to understand the mechanisms behind muscle hypertrophy, recovery, and body composition, few compounds command as much attention as IGF-1 LR3 (Insulin-like Growth Factor 1 Long Arginine 3). This synthetic analog of natural IGF-1 is engineered for enhanced potency and extended biological activity, making it one of the most powerful tools for researching muscle cell proliferation, hyperplasia, and protein synthesis. This Dragon Pharma IGF-1 LR3 1mg offering delivers high-purity lyophilized powder in a sterile 2mL vial, providing researchers with a premium compound for investigating anabolic pathways and tissue regeneration mechanisms.
IGF-1 is a key mediator of growth hormone's anabolic effects, acting directly on muscle cells to promote satellite cell activation, amino acid uptake, and protein synthesis. The LR3 (Long Arginine 3) modification involves substituting arginine for glutamic acid at position 3, which significantly reduces binding to IGF-binding proteins (IGFBPs), dramatically extending the peptide's half-life and bioavailability. Research published in the NIH PubMed database demonstrates that IGF-1 LR3 exhibits enhanced potency compared to native IGF-1, with the ability to promote muscle cell differentiation and proliferation even in the presence of inhibitory binding proteins.
The relevance of IGF-1 LR3 to athletic performance is profound. Unlike growth hormone, which works indirectly through IGF-1 production in the liver, exogenous IGF-1 LR3 acts directly on target tissues, bypassing the hepatic conversion step. This direct action promotes hyperplasia—the creation of new muscle fibers—a mechanism distinct from hypertrophy (enlargement of existing fibers). For bodybuilders seeking to maximize long-term growth potential, hyperplasia represents a frontier in muscle development research. Additionally, IGF-1 LR3 enhances glucose uptake into muscle cells, improves nitrogen retention, and supports collagen synthesis for connective tissue health—all critical factors for athletes engaged in intense training cycles.
Quality assurance is paramount in peptide research. Each batch of our IGF-1 LR3 1 mg inventory undergoes rigorous third-party HPLC-MS testing to verify purity and dosage. The most recent batch (January 2024) tested at an exceptional 1.05 mg—exceeding the label claim—with batch number #IGFHD6. This level of transparency and quality control ensures that researchers can trust the integrity of the compounds they are investigating.
For bodybuilders and strength athletes navigating the demands of off-season growth or post-injury recovery, IGF-1 LR3 offers a unique research avenue. Its extended half-life allows for less frequent administration compared to native IGF-1, while its enhanced potency means lower effective doses. Whether investigating strategies for muscle hyperplasia, localized site growth, or systemic anabolic enhancement, Dragon Pharma's IGF-1 LR3 delivers the purity, potency, and reliability required for serious research into the most powerful anabolic pathways.
Note: This product is intended for laboratory research and scientific investigation purposes only. Not for human consumption or veterinary use.
Usage Guidelines
IGF-1 LR3 is supplied as a sterile lyophilized powder and must be reconstituted with bacteriostatic water or sterile saline prior to research use. Due to the sensitive nature of this peptide, handle with care—gently swirl the vial after adding the diluent; do not shake vigorously. Standard research protocols often involve reconstituting the 1mg peptide with 1-2mL of bacteriostatic water, yielding a concentration of 0.5-1mg/mL. For precise dosing, utilize a sterile insulin syringe. Typical research dosing ranges from 20-80mcg per day, often administered post-workout to coincide with the anabolic window. Due to its extended half-life, IGF-1 LR3 requires only once-daily administration. It is recommended to store the reconstituted peptide in a refrigerator (2-8°C) and use within 30 days to maintain peptide integrity.
For researchers investigating comprehensive anabolic and recovery protocols, combining IGF-1 LR3 with complementary peptides can yield synergistic insights. Consider exploring the following Dragon Pharma products to enhance your research:
- MK 677: An oral growth hormone secretagogue that elevates IGF-1 levels through endogenous GH stimulation for comparative research.
- BPC 157: A regenerative peptide often studied alongside IGF-1 for comprehensive tissue repair and recovery protocols.
- TB 500: A thymosin beta-4 derivative researched for its synergistic effects with IGF-1 on tissue remodeling and healing.